These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31964157)

  • 1. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
    Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
    Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
    Wang N; Feng Y; Tan HY; Cheung F; Hong M; Lao L; Nagamatsu T
    J Ethnopharmacol; 2015 Apr; 164():309-18. PubMed ID: 25700642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
    Li M; Shang H; Wang T; Yang SQ; Li L
    World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
    Yin B; Bi YM; Fan GJ; Xia YQ
    J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.
    Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X
    J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction.
    He MY; Deng YX; Shi QZ; Zhang XJ; Lv Y
    J Ethnopharmacol; 2014 Aug; 155(1):334-42. PubMed ID: 24910405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis.
    Liang J; Huang Y; Mai Z; Zhan Q; Lin H; Xie Y; Wang H; Liu Y; Luo C
    Drug Des Devel Ther; 2021; 15():1779-1795. PubMed ID: 33958856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
    Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
    Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the modified Huanglian Jiedu decoction on the disease resistance in grey mullet (Mugil cephalus) to Lactococcus garvieae.
    Choi WM; Lam CL; Mo WY; Cheng Z; Mak NK; Bian ZX; Wong MH
    Mar Pollut Bull; 2014 Aug; 85(2):816-23. PubMed ID: 24846297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.
    Li X; Wei S; Niu S; Ma X; Li H; Jing M; Zhao Y
    Comput Biol Med; 2022 May; 144():105389. PubMed ID: 35303581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Network Pharmacology and Experimental Models to Investigate the Mechanism of Huanglian Jiedu Decoction on Inflammatory Injury Induced by Cerebral Ischemia.
    Li H; Lv T; Wang B; Li M; Liu J; Wang C; Tang Z
    Evid Based Complement Alternat Med; 2021; 2021():2135394. PubMed ID: 33519941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
    Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
    Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12.
    Lin J; Gu M; Wang X; Chen Y; Chau NV; Li J; Chu Q; Qing L; Wu W
    J Ethnopharmacol; 2024 Jun; 328():118125. PubMed ID: 38561055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
    Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
    Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
    Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
    J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis.
    Zhou G; Lin L; Wang S; Dong M; Lu K; Zhang Y; Lin Z; Lin J; Wu W; Peng R; Luo C
    Int Immunopharmacol; 2024 Oct; 140():112834. PubMed ID: 39116495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology.
    Gong Z; Li R; Chen S; Wu H; Cai Y; Li J; Zhao X; Chu Q; Luo C; Qing L; Li N; Wu W
    J Healthc Eng; 2022; 2022():2457706. PubMed ID: 36061816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.